NO992468L - Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs - Google Patents

Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs

Info

Publication number
NO992468L
NO992468L NO992468A NO992468A NO992468L NO 992468 L NO992468 L NO 992468L NO 992468 A NO992468 A NO 992468A NO 992468 A NO992468 A NO 992468A NO 992468 L NO992468 L NO 992468L
Authority
NO
Norway
Prior art keywords
nsaids
treatment
composition
gastrointestinal disorders
containing bismuth
Prior art date
Application number
NO992468A
Other languages
Norwegian (no)
Other versions
NO992468D0 (en
Inventor
Jonathan Davidson Kaunitz
Owen Rickford Carryl
Shin Tanaka
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO992468D0 publication Critical patent/NO992468D0/en
Publication of NO992468L publication Critical patent/NO992468L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse vedrører fremgangsmåter og sammen- setninger for å behandle en gastrointestinal forstyrrelse forårsaket eller mediert av Helicobacter pylori, hvilke omfatter vismut, og en gastropatisk mengde av et ikke- steroidalt anti-inflammatorisk medikament. Oppfinnelsen kan ytterligere inneholde terapeutiske effektive mengder av ett eller flere anti-sekretoriske medikamenter.The present invention relates to methods and compositions for treating a gastrointestinal disorder caused or mediated by Helicobacter pylori, which includes bismuth, and a gastropathic amount of a non-steroidal anti-inflammatory drug. The invention may further contain therapeutically effective amounts of one or more anti-secretory drugs.

NO992468A 1996-11-22 1999-05-21 Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs NO992468L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75551796A 1996-11-22 1996-11-22
PCT/US1997/021462 WO1998022118A1 (en) 1996-11-22 1997-11-21 Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid

Publications (2)

Publication Number Publication Date
NO992468D0 NO992468D0 (en) 1999-05-21
NO992468L true NO992468L (en) 1999-07-01

Family

ID=25039481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992468A NO992468L (en) 1996-11-22 1999-05-21 Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs

Country Status (7)

Country Link
EP (1) EP0941102A1 (en)
CN (1) CN1238694A (en)
CA (1) CA2271381A1 (en)
HU (1) HUP9904073A3 (en)
NO (1) NO992468L (en)
TR (1) TR199901101T2 (en)
WO (1) WO1998022118A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AU781133B2 (en) * 1999-02-26 2005-05-05 Nicox S.A. Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
TWI275587B (en) * 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
US7285668B2 (en) * 2000-12-01 2007-10-23 Takeda Pharmaceutical Company Limited Process for the crystallization of (R)- or (S)-lansoprazole
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6514960B1 (en) * 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
KR101148399B1 (en) * 2005-06-22 2012-05-23 일양약품주식회사 Pharmaceutical Composition for Treating Gastric Disease Containing Antiulcerent and Mucosal Protective Agents
JP2011513202A (en) 2008-03-10 2011-04-28 武田薬品工業株式会社 Crystals of benzimidazole compounds
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
MX2014007935A (en) 2011-12-28 2014-11-14 Pozen Inc Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid.
WO2023143573A1 (en) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 Use of bismuth-containing compound in treatment of diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI910088A (en) * 1990-01-09 1991-07-10 Gist Brocades Nv ORAL PHARMACEUTICAL COMPOSITION.
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
WO1993009784A1 (en) * 1991-11-22 1993-05-27 The Procter & Gamble Company Unit dose form of bismuth subsalicylate
ES2130152T3 (en) * 1991-12-06 1999-07-01 Glaxo Group Ltd MEDICINES TO TREAT INFLAMMATORY PAIN OR ANALGESIA CONTAINING A NSAID AND RANITIDINE / BISMUTE CITRATE.

Also Published As

Publication number Publication date
HUP9904073A3 (en) 2000-04-28
HUP9904073A2 (en) 2000-03-28
WO1998022118A1 (en) 1998-05-28
EP0941102A1 (en) 1999-09-15
TR199901101T2 (en) 1999-07-21
NO992468D0 (en) 1999-05-21
CN1238694A (en) 1999-12-15
CA2271381A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
NO992468L (en) Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs
NZ235877A (en) Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
NO992469L (en) Compositions containing bismuth and NSAIDs and one or more antimicrobial agents for the treatment of gastrointestinal disorders
DK0963200T3 (en) Preparations for inhibiting angiogenesis comprising thalidomide and an NSAID
DK0754176T3 (en) Newly known carbamates and ureas as modifiers for multidrug resistance
DK0862424T3 (en) Pharmaceutical compositions comprising flurbiprofen
ATE525061T1 (en) SOLID SELF-ADHESIVE COMPOSITIONS FOR THE TOPICAL TREATMENT OF DISORDERS OF THE ORAL MUCOSA
DK1024815T3 (en) Pharmaceutical composition for oral administration of molecular iodine
IT1212778B (en) PHARMACEUTICAL COMPOSITIONS ANTI-INFLAMMATORY AND / OR ANALGESIC ADAPTERITY, NON ULCEROGENE.
PT705100E (en) THERAPEUTIC SUBSTITUTED GUANIDINS
NO976048L (en) Pharmaceutical and diet formulations for prophylaxis and treatment of gastrointestinal disorders
ATE106737T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS.
DK1032556T3 (en) Pharmaceutically active compounds and methods of use
PL323617A1 (en) Pharmaceutical preparation for treating oestrogen-dependent carcinomas
DE69927584D1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF STOMACH DISEASES
TR199800421A2 (en) Bismuth salts of moenomycin group antibiotics.
MX9305510A (en) COMPOUNDS FOR THE TREATMENT OR PROPHYLAXIS OF GASTROINTESTINAL, CARDIOVASCULAR AND CENTRAL NERVOUS SYSTEM DISORDERS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
DK554585D0 (en) PHARMACEUTICAL INCLUDING A COMPOUND OF AT LEAST ONE IMMUNOTOXIN AND AT LEAST ONE MANNOSE-CONTAINING POLYMER
DK1073436T3 (en) Improved method for eradication of Helicobacter pylori
NO982562L (en) Composition for the treatment of pain
IL127143A0 (en) Phospholipid terivatives of non-steroidal anti inflammatory drugs
ATE44461T1 (en) ANALGESIC COMPOSITIONS.
FR2707455B1 (en) Preventing the reproduction of xylophagous insects, means for the preventive treatment of the wood material used.
SE8504612L (en) ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS INCLUDING DIPHENHYDRAMIN AND PROCEDURES FOR USING THESE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application